Skip to main content

Review of any APTA confidential draft allows us to improve the overall guideline/review, but does not imply endorsement by any given individual or specialty society who participates in the review process.

Please note that if you return a review:

  1. Your review comments will be published on the APTA website with our explanation of why we did or did not change the draft document in response to your comments.
  2. Your name and conflicts of interest disclosures will be published on the APTA website alongside your review comments. 

Structured Peer Review Form Instructions

Please read and review this Draft Clinical Practice Guideline. Your responses will be used to assess the validity, clarity and accuracy of the interpretation of the evidence.

If you have any questions please e-mail Jeanine Kolman, Practice Department, American Physical Therapy Association. Thank you in advance for your time in completing this form and giving us your feedback. We value your input and greatly appreciate your efforts. 

Please note: This web form will NOT save your progress if you initiate the form but do not complete it. It is recommended that you compile your feedback and suggested edits before starting the form.

May we list your society as a reviewer of this guideline?

Peer Review Questions (1 = strongly disagree; 7 = strongly agree)

1. The overall objective of the guideline is specifically described.
2. The population to whom the guideline is meant to apply is specifically described.
3. The guideline development group includes individuals from all relevant professional groups.
4. The views and preferences of target populations have been sought.
5. The target users of the guideline are clearly defined.

6. Systematic methods were used to search for evidence.
7. The criteria for selecting the evidence are clearly described.
8. The strength and limitations of the body of evidence are clearly described.
9. The methods for formulating the recommendations are clearly described.
10. The health benefits, side effects and risks have been considered in formulating the recommendations.

11. There is an explicit link between the recommendations and the supporting evidence.
12. A procedure for updating the guideline is provided.
13. The recommendations are specific and unambiguous.
14. The different options for management of the condition or health issue are clearly presented.
15. The guideline provides advice and/or tools on how the recommendations can be put into practice.

16. Competing interests of the guideline development group members have been recorded and addressed.
17. Rate the overall quality of this guideline. (1 = lowest possible quality; 7 = highest possible quality)
18. I would recommend this guideline for use.

Additional comments or suggested edits section (optional).

Please use the boxes below and make sure to indicate associated line number for each comment.

An error has occurred while getting captcha image

When you have completed the form, click "Submit" to submit all responses.

Share This